SL-11047 in Treating Patients With Relapsed or Refractory Lymphoma

Summary

RATIONALE: Drugs used in chemotherapy, such as SL-11047, work in different ways to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. PURPOSE: This phase I trial is studying the side effects and best dose of SL-11047 in treating patients with relapsed or refractory lymphoma.

Timeline

Start

2006-01

Primary completion

2008-09

Completion

—

Drugs

Indications